External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil.

External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil.
Emerg Infect Dis. 2018 May 17;24(5):
Authors: Fischer C, Pedroso C, Mendrone A, Bispo de Filippis AM, Vallinoto ACR, Ribeiro BM, Durigon EL, Marques ETA, Campos GS, Viana IFT, Levi JE, Scarpelli LC, Nogueira ML, Bastos MS, Souza NCS, Khouri R, Lira S, Komninakis SV, Baronti C, Charrel RN, Kümmerer BM, Drosten C, Brites C, de Lamballerie X, Niedrig M, Netto EM, Drexler JF
Abstract
We conducted an external quality assessment of Zika virus molecular diagnostic tests in Brazil using a new Zika virus standard. Of 15 laboratories, 73% showed limited sensitivity and specificity. Viral load estimates varied significantly. Continuous quality assurance is needed to adequately estimate risk for Zika virus-associated disease and determine patient care.
PMID: 29470164 [PubMed - as supplied by publisher]

Source: Emerging Infectious Diseases - February 23, 2018 Category: Infectious Diseases Authors: Fischer C, Pedroso C, Mendrone A, Bispo de Filippis AM, Vallinoto ACR, Ribeiro BM, Durigon EL, Marques ETA, Campos GS, Viana IFT, Levi JE, Scarpelli LC, Nogueira ML, Bastos MS, Souza NCS, Khouri R, Lira S, Komninakis SV, Baronti C, Charrel RN, Kümmerer B Tags: Emerg Infect Dis Source Type: research